Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-10

Clinical Trial Update: Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS) [Phase 2, Phase 3]

View source ↗

Summary

This entry describes a Phase 2/Phase 3 clinical trial comparing semaglutide to metformin for Polycystic Ovary Syndrome, sponsored by the University of Hull, whi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)
  • semaglutide (semaglutide)

Snippet

Sponsor: University of Hull | Conditions: Polycystic Ovary Syndrome | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING